Graphic: Naveen Kumar Saini/Mint

• if the National List of Essential Medicines, 2011, is implemented, as much as 24-29% of domestic revenue of some large companies will come under price control, Barclays Research has estimated. Currently, only 2.5-6.8% of local revenue is under price control under the Drugs (Prices Control) Order, 1995.